Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tirzepatide delays gastric emptying, and Zepbound trials reported belching in 4% to 5% of dose groups versus 1% with placebo
Rather, it suggests those effects may be more subtleor harder to measurethan many people assume
Improved Metabolic Health: In addition to weight loss, GLP-1 can lead to improvements in various cardiometabolic risk factors, including reduced inflammation and improvements in blood pressure, triglyceride levels, and cholesterol levels
The company also helps its users learn if GLP-1 medications are covered by their insurance, so Ro takes on benefits verification and works with a partner to optimize prior authorizations, giving patients treatment options, coverage details, and cost estimates
doi:10.1172/jci.insight.140532
